One of the purposes of CANCER IMMUNOTHERAPY & IMMUNOMONITORING Conference
is to provide educational activities that should maintain, improve and
further develop the investigation and practice of malignant diseases.
The target audience for CITIM Conference includes biomedical
scientists, medical students, immunologists, medical oncologists,
surgical oncologists, hematologists, pathologists, specialty and
primary care physicians, and allied health professionals.